Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis. - Wikidata - awgldk - TriplyDB

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

http://www.wikidata.org/entity/Q35987881

about

Interventions for dialysis patients with hepatitis C virus (HCV) infection Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review Hepatitis C infection in hemodialysis patients: A review Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response Causal inference regarding infectious aetiology of chronic conditions: a systematic review.Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study.Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis.Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.Hepatitis C and kidney disease: An overview and approach to management.Effect of kidney transplantation on outcomes among patients with hepatitis C A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C.Hepatitis C and kidney transplantation Hepatitis C in hemodialysis patients Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients.Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.Hepatitis C virus and its renal manifestations: a review and update Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients.The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures.Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis.Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection.Hepatitis C and renal transplantation.Hepatitis C infection and chronic renal diseases.Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients.Hepatitis E Virus Infection Among Chronic Hemodialysis.Histological features of chronic hepatitis C in haemodialysis patients.Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study.Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease.Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease.Viral hepatitis in solid organ transplantation.Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China.Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis.Should ribavirin be used to treat hepatitis C in dialysis patients?Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.Hepatitis status and mortality in hemodialysis population.Seroprevalence occurrence of viral hepatitis and HIV among hemodialysis patients.

P2860

Q24187826-78B107EE-C77F-4DA8-93D5-C5A87E4ED903 Q26821786-500A3E86-3C85-445E-B3DF-E51025401EA3 Q27009100-291D75FA-4910-4E10-BB61-BD031EF143F8 Q27489433-AD7EFDB8-4F0B-48AD-88EC-6F1B7D422D22 Q31126057-7C6A613D-1C90-4840-B8A0-8B1657577097 Q33277945-DB846D45-CF21-42F3-88E2-8126412238B9 Q33969758-13B356A5-9437-4300-AA56-A363A741081C Q34926896-5DCA6030-2026-433A-87BF-C78CE1FD9B5B Q34966853-EECC2E08-AE67-4692-AD8C-A18E36219D43 Q35012447-A57F6C4C-7736-4EF3-AAEE-67EC0860768C Q35072818-37CA8A0A-2A75-4D49-B170-08BE253C81DE Q35094769-FBEFE2EB-076C-4374-BF61-5B7CDE0ED341 Q35237329-DE6E4246-F072-4DB9-B607-441F48AFBBB6 Q35507593-37E7C3BE-83B6-4FF3-96A7-C1AE9824F356 Q35532440-7AA07C46-8C23-4EBD-BE44-982950049CDD Q35985941-D8CCB8A1-A6AE-4367-9ABB-54CEB657821B Q36496970-0B5B2C80-CA60-469A-84F1-0890E75BB90A Q36843489-E6CE1B2A-5476-48A8-8656-758DBBDDDDC2 Q36944054-EE402D34-2A2D-4375-84E5-2452A5B81ABF Q37088857-F403CD2F-0313-4823-ACB8-E8C603843646 Q37692546-B215D5D3-004E-4D6E-81BD-73272548ACFC Q37697588-4AAF9055-8A13-40D0-978C-EEFCDBC955E9 Q38017157-6CC10D35-2DED-4A15-B642-981F266989F8 Q38552198-54BBCBA5-412A-410A-979A-1113CFB8CFAF Q38975165-30D4A641-9862-406B-8DBD-C3D8086FC985 Q40658865-4000C7EB-C912-4C36-AD98-519E6214CD6F Q41734101-22C73070-D40C-4022-9E27-C740546272F9 Q41921995-B265BED6-4363-42EE-9D69-82A7BFDDD133 Q41925546-D7E325A8-D4B5-4D58-B255-EC413C40C8EC Q42206661-F8304F2F-3EF0-4ED4-A805-63F89C90D651 Q42251188-E8B9EE6D-8689-4D06-909E-C4FF62E56A6D Q42272319-ECE1673F-3FE8-4BD6-A20F-4555DC2590F7 Q42988519-966D5D7E-1C9D-43BA-BED3-7101CCAED227 Q45400047-0769A02F-9D8B-49A5-994D-7138E5E09AC2 Q45867154-72E4E33D-F961-43EB-81E5-A92CC257F0D1 Q50556069-740D06C8-5690-4784-8CBE-637025027801 Q51662874-03703C6A-53E2-4C14-90B8-F481687B8022 Q52564573-6EDF614B-9E39-4ABA-8F76-D5E78C257AF6

P2860

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

http://www.wikidata.org/entity/Q35987881

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@ast

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@en

type

label

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@ast

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@en

prefLabel

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@ast

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@en

P1433

Q35987881-C8D2C4DF-A861-4ECD-A3D9-B21228F51474

P1476

Q35987881-7AC6DE1B-7A52-4058-B876-A9BA2DFC1C78

P2093

Q35987881-53C2D8C2-C380-43C8-99AB-0E7756F258AF

Q35987881-57F2AAA8-8F24-4E3A-88A1-59A0161ACBE9

Q35987881-5AB12865-FC9E-464F-8801-4DA1E9683330

Q35987881-6F027758-D5E7-4B31-978D-C92C9C75F299

Q35987881-AD576200-EF63-47B6-A557-6350DD865D07

P2860

Q35987881-03433AF6-DF33-4E21-9495-215C413085BD

Q35987881-04366F53-28AE-48B6-B92C-BA9F49EB1D9C

Q35987881-16646DC5-B9FC-43F5-838E-2D79A39C5743

Q35987881-4068643D-F329-4ECD-B6F7-0E18825F4814

Q35987881-463100D9-7C26-4866-A014-40AF8B8C123C

Q35987881-83121E4D-9AB4-4EC7-AFD4-A93BBC915C90

Q35987881-A17C5AC2-BFD2-4291-B032-62C0DC914544

Q35987881-ADAC30CC-2ACB-4929-82EC-F2FEAC27D31D

Q35987881-B2D63BC9-17B2-48C3-AD96-8615F7DE006D

Q35987881-B962892E-EEEC-4F1C-AEAB-E978746AD470

P304

Q35987881-F34E1AB9-2BB1-443A-993E-B4CFFF5A0BC9

P31

Q35987881-0A810F2C-6324-46B8-949A-0834687E698D

Q35987881-2b961933-1bff-436b-9daf-18b194c90074

P356

Q35987881-4DB45976-0BF3-41B5-B683-715A0085275B

P407

Q35987881-ABF1565D-7900-4E1B-8FE9-FABB88F33F49

P433

Q35987881-937439C5-A4DD-47FD-8935-402934FA70CC

P478

Q35987881-32367854-CC4D-43CB-96E1-9BCAB68B1ACD

P577

Q35987881-3A22DFE7-C1F8-4973-83FC-2F8DFEFA86A0

P5875

Q35987881-467F022D-60AB-409B-856F-270315FA2384

P698

Q35987881-D7181069-8F86-4B80-8E64-6EB85564365D

P921

Q35987881-6BB2C678-0F7D-4DBC-AB37-7C65A267942B

P356

J.1365-2036.2004.02290.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.

@en

P2093

Bunnapradist S

http://www.w3.org/2001/XMLSchema#string

Dixit V

http://www.w3.org/2001/XMLSchema#string

Dulai G

http://www.w3.org/2001/XMLSchema#string

Fabrizi F

http://www.w3.org/2001/XMLSchema#string

Martin P

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis in clinical trials

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Hepatitis C infection and the patient with end-stage renal disease.

Host defenses and immunologic alterations associated with chronic hemodialysis.

Histopathological features of hepatitis C in renal transplant candidates [see comment]

Liver disease in dialysis patients with antibodies to hepatitis C virus.

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.

Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus.

Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies.

P304

1271-1277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2004.02290.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8124436

http://www.w3.org/2001/XMLSchema#string

P698

15606388

http://www.w3.org/2001/XMLSchema#string

P921